← Back to Search

Fatherhood Engagement Program for Substance Use Disorders

N/A
Recruiting
Led By Scott Wetzler, PhD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow up (6-months after baseline)
Awards & highlights

Study Summary

This trial will help Bronx families at risk of substance misuse get enhanced services, incl. motivational enhancement, a fatherhood program, & case management.

Who is the study for?
This trial is for fathers, whether they live with their children or not, who have at least one child under 18. They must be part of a family where someone is at risk for substance use issues. Fathers whose children are all in foster care cannot participate.Check my eligibility
What is being tested?
The study tests if extra support services can help fathers in families at risk of substance misuse. Some dads will get usual services; others will also get motivational talks, the HERO Dads program, rewards for positive behavior (Contingency Management), and Case Management.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort or stress due to the sensitive nature of the topics discussed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow up (6-months after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow up (6-months after baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child well-being, as measured by: Child Behavior Checklist

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Fatherhood Services through Regional Partnership Grant Round 7 (RPG7)Experimental Treatment4 Interventions
Randomly assigned to receive enhanced RPG7 services (motivational enhancement, fatherhood engagement services, contingency management, case management)
Group II: Services as UsualActive Control1 Intervention
Randomly assigned to receive services as usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational Enhancement
1999
Completed Phase 3
~2290
Contingency Management
2003
Completed Phase 2
~3220
Case Management
2012
Completed Phase 2
~2890

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
443 Previous Clinical Trials
582,296 Total Patients Enrolled
Albert Einstein College of MedicineOTHER
287 Previous Clinical Trials
11,856,868 Total Patients Enrolled
Scott Wetzler, PhDPrincipal InvestigatorMontefiore Medical Center
3 Previous Clinical Trials
3,976 Total Patients Enrolled

Media Library

HERO Dads Fatherhood Program Clinical Trial Eligibility Overview. Trial Name: NCT05562557 — N/A
Substance Abuse Research Study Groups: Services as Usual, Enhanced Fatherhood Services through Regional Partnership Grant Round 7 (RPG7)
Substance Abuse Clinical Trial 2023: HERO Dads Fatherhood Program Highlights & Side Effects. Trial Name: NCT05562557 — N/A
HERO Dads Fatherhood Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05562557 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current experimental research recruiting new participants?

"Absolutely. Clinicaltrials.gov confirms that the trial, first unveiled on May 9th 2023 is currently recruiting participants. 240 individuals need to be enrolled from one particular medical centre."

Answered by AI

To what number of participants has this clinical test been administered?

"Affirmative. Clinicaltrials.gov states that this medical trial, originally made available on May 9th 2023, is now actively searching for participants. A total of 240 patients are needed at one location to complete the study's requirements."

Answered by AI
~160 spots leftby Sep 2027